Opaleye Management Inc. - 15 Sep 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Issuer symbol
TELA
Transactions as of
15 Sep 2022
Net transactions value
+$52,853
Form type
4
Filing time
16 Sep 2022, 17:47:14 UTC
Previous filing
15 Sep 2022
Next filing
19 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock, par value $0.001 per share Purchase $28,350 +3,500 +0.19% $8.10 1,888,500 15 Sep 2022 By Opaleye, L.P. F1
transaction TELA Common Stock, par value $0.001 per share Purchase $5,330 +658 +0.55% $8.10 120,875 15 Sep 2022 By Managed Account F2
transaction TELA Common Stock, par value $0.001 per share Purchase $16,166 +2,000 +0.11% $8.08 1,890,500 16 Sep 2022 By Opaleye, L.P. F1, F3
transaction TELA Common Stock, par value $0.001 per share Purchase $3,007 +372 +0.31% $8.08 121,247 16 Sep 2022 By Managed Account F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
F3 This transaction was executed in multiple trades at prices ranging from $8.0786 to $8.085; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.